Towa Pharmaceutical Revenue

Towa Pharmaceutical had revenue of 70.33B JPY in the quarter ending December 31, 2024, with 15.43% growth. This brings the company's revenue in the last twelve months to 253.35B, up 7.00% year-over-year. In the fiscal year ending March 31, 2024, Towa Pharmaceutical had annual revenue of 227.93B with 9.13% growth.

Revenue (ttm)

253.35B

Revenue Growth

+7.00%

P/S Ratio

0.52

Revenue / Employee

55.22M

Employees

4,588

Market Cap

132.91B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	227.93B	19.08B	9.13%
Mar 31, 2023	208.86B	43.24B	26.11%
Mar 31, 2022	165.62B	10.72B	6.92%
Mar 31, 2021	154.90B	44.52B	40.33%
Mar 31, 2020	110.38B	5.28B	5.02%
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro
Mar 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chugai Pharmaceutical	1,170.61B
Takeda Pharmaceutical Company	4,579.02B
Daiichi Sankyo Company	1,795.99B
HOYA Corporation	837.44B
Terumo	1,011.15B
Otsuka Holdings	2,329.86B
Astellas Pharma	1,867.63B
Olympus	993.33B

Revenue Rankings